Sentences with phrase «of ovarian cancer cases»

If you do need treatment, select a cancer center that handles a high number of ovarian cancer cases.

Of the ovarian cancer cases the investigators studied, 19 percent of them carried rare germline truncations.

In earlier research, Barbolina discovered that a fractalkine receptor — a protein found on the cell surface — is expressed in the majority of ovarian cancer cases.

Not exact matches

Yet 20 % of women diagnosed with lung cancer each year — about 21,000 in 2010, roughly the same number as new cases of ovarian cancer — never smoked.

We modeled cases of breast cancer, premenopausal ovarian cancer, hypertension, type 2 diabetes mellitus, and myocardial infarction considering direct costs, indirect costs, and cost of premature death (before age 70 years) expressed in 2011 dollars.

In many sorts of court cases, from whether talcum powder causes ovarian cancer to The People v. O.J. Simpson, statistics play (or ought to play) a vital role in...

When the researchers recalculated the PPV using ovarian cancer's true frequency in the general U.S. population of one case for every 2,500 postmenopausal women, the PPV plummeted to just 6.5 percent.

«Because there is currently no reliable screening available for ovarian cancer, most cases are diagnosed at advanced stages,» said the study's author, Bo (Bonnie) Qin, PhD, a postdoctoral associate at Rutgers Cancer Institute of New Jcancer, most cases are diagnosed at advanced stages,» said the study's author, Bo (Bonnie) Qin, PhD, a postdoctoral associate at Rutgers Cancer Institute of New JCancer Institute of New Jersey.

The National Cancer Institute estimates that at least 21,000 new cases of ovarian cancer will be diagnosed in the U.S. in 2010, and nearly 14,000 women will die of the disease, making it the deadliest of the female reproductive caCancer Institute estimates that at least 21,000 new cases of ovarian cancer will be diagnosed in the U.S. in 2010, and nearly 14,000 women will die of the disease, making it the deadliest of the female reproductive cacancer will be diagnosed in the U.S. in 2010, and nearly 14,000 women will die of the disease, making it the deadliest of the female reproductive cancers.

Using genome data from more than 50,000 cancer cases and 60,000 controls through the GAME - ON (Genetic Associations and Mechanisms in Oncology) network, the team compared telomere lengths with the risk of developing breast, lung, colorectal, ovarian and prostate cancers, including subtypes.

In order to assess whether an improved diet could reduce the risk of ovarian cancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Scancer in African - American women, Qin analyzed the diets of 415 women with ovarian cancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Scancer and 629 control patients, using data from the African - American Cancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United SCancer Epidemiology Study, a population - based case - control study of ovarian cancer in African - American women in 11 sites in the United Scancer in African - American women in 11 sites in the United States.

Diamond is also quick to point out that while the current study shows that COXEN could have been used to predict the most useful drug in many of these cases of advanced ovarian cancer, the actual use of the model will be possible only after validation with a prospective clinical trial.

Acknowledging that «this is not a big study, in terms of the overall number of cases, for ovarian cancer it's a very big study,» explains Annekatrin Lukanova of the International Agency for Cancer Research in Lyon, Fcancer it's a very big study,» explains Annekatrin Lukanova of the International Agency for Cancer Research in Lyon, FCancer Research in Lyon, France.

For instance, a plaintiff in the Supreme Court case, Ellen T. Matloff of Yale Cancer Center, said that in 2006 she knew of a patient who had had breast and ovarian cancer who tested negative for BRCA1 and BRCA2, suggesting that this patient's cancers were not the result of a hereditary condition, according to the New York Cancer Center, said that in 2006 she knew of a patient who had had breast and ovarian cancer who tested negative for BRCA1 and BRCA2, suggesting that this patient's cancers were not the result of a hereditary condition, according to the New York cancer who tested negative for BRCA1 and BRCA2, suggesting that this patient's cancers were not the result of a hereditary condition, according to the New York Times.

When COXEN looked back through this registry of advanced ovarian cancer, it first sorted tumors into those that had responded and those that had not responded to each drug («what would have been the right drug in each case»).

«By combining my laboratory's expertise in ovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Meovarian cancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medcancer biology and Dr. Xu's expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Meovarian cancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medcancer,» said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MeOvarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MedCancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of MedCancer Center at Case Western Reserve University School of Medicine.

In 2011, 20,797 cases of ovarian cancer, 47,824 cases of uterine cancer, and 12,187 cases of cervical cancer were reported nationally.

The serial pattern was compared with known cases of cancer and controls to estimate the risk of having ovarian cancer.

About one third of cancer cases are estimated to be linked to dietary and other modifiable risk factors, especially for obesity - related cancers such as breast, colorectal, ovarian, endometrial, kidney, gallbladder, esophageal, and pancreatic cancers.

Sood and colleagues looked at samples from 80 cases of human ovarian cancer grouped according to patient stress using the National Institutes of Health's Center for Epidemiological Studies Depression scale as a surrogate marker.

There are over 22,000 cases of ovarian cancer diagnosed annually in the United States alone.

In many sorts of court cases, from whether talcum powder causes ovarian cancer to The People v. O.J. Simpson, statistics play (or ought to play) a vital role in evaluating the evidence.

Analysing blood samples from a study of 100,000 women showed that, in 88 per cent of cases, the test could detect ovarian cancer 1 to 2 years before it is usually diagnosed (Genome Medicine, doi.org/ch2m).

They found that cases of ovarian cancer linked to genes inherited from the paternal grandmother had an earlier age - of - onset than cases linked to maternal genes, and were also associated with higher rates of prostate cancer in fathers and sons.

Additional sequencing led the researchers to identify a previously unknown mutation on the X-chromosome that may be associated with cases of ovarian cancer that develop more than 6 years earlier that average.

This observation suggests that there may be many cases of seemingly sporadic ovarian cancer that are actually inherited, and may lead to improved cancer screening and better genetic risk assessment.

An estimated 22,240 new cases of ovarian cancer are expected in the U.S. in 2013.

Some of the factors associated with an increased likelihood of a BRCA1 or BRCA2 mutation include breast cancer diagnosis before age 50; both breast and ovarian cancers; multiple breast cancers; cases of male breast cancer and Ashkenazi Jewish ethnicity.

The approach developed by the MGH team starts with the engineered protein, which in this case fuses an antibody fragment targeting a protein called mesothelin — expressed on the surface of such tumors as mesothelioma, ovarian cancer and pancreatic cancer — to a protein from the tuberculosis bacteria that stimulates the activity of dendritic and other immune cells.

Fewer women are getting the disease The rate of new cases of ovarian cancer has declined by 1 % each year since 1992 (about 22,000 women will be diagnosed this year)-- possibly because so many women today are on the Pill, says Deborah Armstrong, MD, associate professor of oncology and OB - GYN at Johns Hopkins Kimmel Cancer Center in Baltcancer has declined by 1 % each year since 1992 (about 22,000 women will be diagnosed this year)-- possibly because so many women today are on the Pill, says Deborah Armstrong, MD, associate professor of oncology and OB - GYN at Johns Hopkins Kimmel Cancer Center in BaltCancer Center in Baltimore.

Women are generally in this group if they have multiple cases of breast or ovarian cancer in the family, a positive result on the BRCA breast cancer gene - mutation test, a personal history of the disease, or a biopsy showing atypia or lobular carcinoma in situ.

Research shows that levels of the 16a OH Estrone metabolites are high in cases of breast, ovarian, cervix, uterine and other hormone - sensitive cancers.

Worldwide, there are more than 204,000 new cases of ovarian cancer annually, accounting for about 4 percent of all cancers diagnosed in women.

A Harvard doctor, Daniel Cramer, studied the link between talcum powder and ovarian cancer for 30 years and testified in court that talcum powder «was likely a contributing factor in 10,000 cases of ovarian cancer annually.»

Juries have not been impressed with Johnson & Johnson's Arguments Out of nowhere, talcum powder ovarian cancer cases became the hottest mass tort case.

Johnson & Johnson must pay $ 72 million to the family of a woman who blamed her fatal ovarian cancer on the company's talcum powder in the first state - court case over the claims to go to trial.

If you have been diagnosed with ovarian cancer or any other injury that may be associated with using these products, be sure to contact the talcum powder injury lawyers at Zinda Law Group of Denver today at 303-800-1501 for a free case consultation.

She has also successfully litigated and settled cases relating to delayed ovarian cancer diagnosis, delayed diagnosis of choroidal melanoma, negligent urgent care treatment involving cellulitis and foot amputation, medical negligence in post-surgical care of prostate ablation and the management of wound care / decubitus ulcers.

In this case, the Los Angeles jury found that Johnson & Johnson had actual knowledge of the link between talc and ovarian cancer.

Similar cases alleging ovarian cancer development as a result of talc use have resulted in verdicts of up to $ 127 million.

Just three days after a Missouri appeals court vacated the first of four monstrous, if scientifically groundless verdicts won since 2015 in St. Louis by plaintiffs alleging their use of talcum powder caused ovarian cancer, a trial judge in Los Angles last Friday reversed a $ 417 million plaintiff's verdict in a comparable case.

Just three days after a Missouri appeals court vacated the first of four monstrous, if scientifically groundless verdicts won since 2015 in St. Louis by plaintiffs alleging their use of talcum powder caused ovarian cancer, a trial judge in Los Angles last Friday reversed a $ 417 million plaintiff's verdict in a comparable case... → Read More: Another Scientifically Groundless Talc Verdict Falls, This Time in Los Angeles

Last year, 21,550 new cases of ovarian cancer were diagnosed among U.S. women; 14,600 deaths were attributed to the disease.

She also has the option of opting for a Critical Illness rider, which would give her a lump sum pay - out in case she was diagnosed with a major disease, such as Ovarian Cancer.